Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0332USD
−6.83 MUSD
247.09 KUSD
106.83 M
About APPILI THERAPEUTICS INC
Sector
CEO
Don Cilla
Headquarters
Halifax
Website
Employees (FY)
9
Founded
2015
FIGI
BBG00TZ8G3G9
Appili Therapeutics, Inc. is a pharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of APLIF is 0.0313 USD — it has increased by 15.48% in the past 24 hours. Watch Appili Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Appili Therapeutics Inc. stocks are traded under the ticker APLIF.
APLIF stock has risen by 12.17% compared to the previous week, the month change is a 13.64% rise, over the last year Appili Therapeutics Inc. has showed a 4.43% decrease.
We've gathered analysts' opinions on Appili Therapeutics Inc. future price: according to them, APLIF price has a max estimate of 0.18 USD and a min estimate of 0.18 USD. Watch APLIF chart and read a more detailed Appili Therapeutics Inc. stock forecast: see what analysts think of Appili Therapeutics Inc. and suggest that you do with its stocks.
APLIF reached its all-time high on May 20, 2020 with the price of 1.3681 USD, and its all-time low was 0.0162 USD and was reached on Feb 20, 2024. View more price dynamics on APLIF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APLIF stock is 34.87% volatile and has beta coefficient of −0.45. Track Appili Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Appili Therapeutics Inc. there?
Today Appili Therapeutics Inc. has the market capitalization of 3.98 M, it has increased by 14.43% over the last week.
Yes, you can track Appili Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Appili Therapeutics Inc. is going to release the next earnings report on Jun 21, 2024. Keep track of upcoming events with our Earnings Calendar.
APLIF net income for the last quarter is −114.94 K USD, while the quarter before that showed −718.84 K USD of net income which accounts for 84.01% change. Track more Appili Therapeutics Inc. financial stats to get the full picture.
No, APLIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 6, 2024, the company has 9.00 employees. See our rating of the largest employees — is Appili Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Appili Therapeutics Inc. EBITDA is −5.93 M USD, and current EBITDA margin is −2.28 K%. See more stats in Appili Therapeutics Inc. financial statements.
Like other stocks, APLIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Appili Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Appili Therapeutics Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Appili Therapeutics Inc. stock shows the neutral signal. See more of Appili Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.